MTS™ (MIC Test Strip)
Support center - Technical sheets
MTS™ Package Insert - IFU
e-IFU latest version | rev.2 - 19/04/2022 |
Introductory: |
|
---|---|
MTS™ Interpretative Criteria and Quality Control | rev.35 - 30/09/2024 |
MTS™ whole range | rev.60 - 11/10/2024 |
US FDA-cleared MTS™ (valid for users based in the US) | last update 19/09/2023 |
MTS™ leaflet | rev.60 - 11/10/2024 |
MTS™ Multi-Language Introduction | rev.35 - 03/01/2020 |
Non Hazardous Product Statement MIC Test Strip | rev.0 - 15/12/2017 |
CE declaration of conformity | rev.37.6 - 22/05/2022 |
MTS30 - Cidal-Static | rev.3 - 08/06/2015 |
Individual drug technical sheet: |
|
---|---|
MTS39 - Ceftobiprole | rev.1 - 24/08/2015 |
MTS40 - Isavuconazole | rev.0 - 30/10/2015 |
MTS44 - Solithromycin | rev.0 - 15/12/2016 |
MTS45 - Fosfomycin | rev.1 - 09/11/2017 |
MTS47 - Cefepime | rev.1 - 20/12/2018 |
MTS49 - Piperacillin-tazobactam for Enterobacterales, Pseudomonas, Acinetobacter | rev.1 - 23/12/2022 |
MTS50 - Piperacillin-tazobactam for Haemophilus, Anaerobes | rev.0 - 17/06/2020 |
MTS51 - Cefiderocol | rev.0 - 03/05/2021 |
MTS52 - Aztreonam-avibactam | rev.0 - 05/10/2022 |
MTS53 - Rezafungin | rev.0 - 29/11/2023 | MTS54 - Cefepime-enmetazobactam | rev.0 - 28/05/2024 | tr>MTS55 - Sulbactam-durlobactam | rev.0 - 21/10/2024 |
Resistance mechanisms detection: |
|
---|---|
MTS26 - ESBL | rev.2.1 - 07/11/2014 |
MTS27 - MBL | rev.4 - 04/06/2021 |
MTS28 - GRD | rev.2.1 - 11/04/2016 |
MTS29 - AmpC | rev.3 - 01/07/2014 |
MTS35 - KPC | rev.4 - 07/08/2015 |